14 July saw BGT break through the 17c support that has been in place since the middle of May.
I believe we have seen capitulation / stop selling last 2 sessions, as impatience steadily grows for those who bought in for the results of the Clarke trial.
To me it seems silly to sell here when you have less than a month for two significant price sensitive catalysts to occur. Clarke and soon after BASF.
Each to their own and this is merely my interpretation of the chart.
BGT Price at posting:
15.5¢ Sentiment: Buy Disclosure: Held
